Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Novartis; Agilent; IntegraGen; Evotec, Apeiron

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Novartis this week said that it will invest more than $600 million over the next five years to expand its global research campus in Cambridge, Mass. The Cambridge site houses the Novartis Institutes for Biomedical Research, Novartis Molecular Diagnostics, Novartis Vaccines and Diagnostics, and the US office of Novartis Venture Funds.

The company expects the investment will include adding 300 jobs, however a company spokesperson declined to provide further details.

Agilent Technologies has opened a new instruments manufacturing facility in Singapore, the firm announced today. The new facility will produce the firm's liquid chromatography/mass spectrometry instruments for the global market.

French molecular diagnostics developer IntegraGen said this week that it will open a US subsidiary based in Cambridge, Mass, on Nov. 1. The new US base will support the firm's clinical research initiatives focused on identifying children at risk of autism. IntegraGen also conducts gene discovery research and provides genotyping services to the research community.

Evotec said this week that it will apply its expertise in cellular assay development in a collaboration with Apeiron Biologics to identify potential targets for pain therapies.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.